Today, Benzinga's options scanner spotted 9 options trades for Amgen. This is not a typical pattern. The sentiment among ...

Amgen (AMGN) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

On Tuesday, Amgen ( AMGN +4.57%) stock hit its one-year high, on continued momentum from a far better-than-expected quarterly ...

The stock of pharmaceutical company Amgen (NASDAQ: AMGN) didn't exactly have a banner trading session on Thursday. In closing the day nearly flat, however, to notch a slight beat on the S&P 500 ...

What Happened: Khosla's recent move involves selling 890 shares of Amgen. This information is documented in a Form 4 filing ...

Amgen (AMGN) is a top biotech value pick with strong sales, robust R&D, and resilient growth. Read here for an analysis of ...

Amgen (AMGN) has caught some attention as its shares continued their upward trend in June, with the stock delivering a 13% ...

Thinking about whether Amgen is a smart buy at today's prices? You are not alone, especially if you are trying to figure out if the current stock price reflects true value or hype. Amgen's share price ...

One of the healthier stocks in the healthcare field Wednesday was Amgen ( AMGN +8.32%). The biotech and pharmaceutical company published its third-quarter results the previous day after market close, ...

Amgen Inc. stock reached a significant milestone, hitting a 52-week high at 335.95 USD. This marks a notable achievement for the biotechnology company, reflecting a strong performance over the past ...

Amgen's weight management candidate looks very promising. The large biotech boasts a deep pipeline beyond that segment. Amgen's dividend looks great, and the stock is reasonably valued. Even so, there ...